Many Hands, One Plan: Inside the Breast Cancer Multidisciplinary Meeting

When you are referred to a breast clinic, it can feel as though one doctor will hold all the answers. In reality, most NHS breast cancer care involves a group of specialists who review your case together. This is known as the multidisciplinary team, or MDT. Understanding who is involved and what they do can make appointments feel less opaque and help you take a more active part in decisions about your care.

What the multidisciplinary team is

The MDT is a group of health professionals with different areas of expertise. In breast cancer care, it usually meets weekly to discuss newly diagnosed cases, complex results and changes in treatment. The team may include breast surgeons, radiologists who review mammograms and scans, pathologists who examine tissue samples, clinical and medical oncologists, and breast care nurses or clinical nurse specialists. A plastic surgeon may join when reconstruction is being considered. Other specialists may attend for particular questions, such as genetic counsellors, fertility specialists, physiotherapists, palliative care clinicians or research nurses. An MDT coordinator usually helps to organise the meetings and record the recommendations.

The purpose is not to make care impersonal. It is to bring different perspectives together so that diagnosis, treatment options and practical considerations are reviewed in one place. This can help reduce the risk of important details being missed and supports consistency with national guidance.

What happens in an MDT meeting

MDT meetings are confidential clinical discussions. A clinician presents each case, usually with imaging, pathology results and relevant medical history. The team discusses the diagnosis, the stage and grade of the cancer, your general health and any factors that may affect treatment choices. They consider the available options, including surgery, radiotherapy, chemotherapy, hormone therapy and clinical trials where appropriate. They also think about the order in which treatments might be given and whether further tests are needed.

The outcome is a recommendation, not a final decision made without you. Your own views, preferences and circumstances should be part of the discussion, often through information shared by your clinician or breast care nurse. The recommendation is then discussed with you at an appointment, where you can ask questions and talk through what matters most to you. If information is missing, the team may ask for another test or arrange to review your case again.

Why you are not usually in the room

The MDT usually discusses many patients in a single meeting, and the conversations are clinical and confidential. For that reason, patients do not normally attend. This does not mean your voice is absent. You can ask your clinician or clinical nurse specialist to share particular concerns with the team, such as your wish to avoid a certain treatment if possible, your caring responsibilities, fertility questions or work commitments.

It is also reasonable to ask whether your case has been discussed at an MDT and what was recommended. You can request a clear explanation of the reasoning behind the recommendation, including the alternatives that were considered.

Preparing for appointments

A little preparation can make a significant difference. Before an appointment, write down your questions and note anything you want the team to know. It can help to bring someone with you, both for support and to remember what was said. If English is not your first language, ask whether an interpreter can be arranged. You may also want to list your priorities, such as returning to work, caring for children or relatives, or understanding the effect of treatment on fertility.

During the appointment, ask for the recommendation to be explained in plain terms. It is acceptable to ask why a particular option is being suggested, what the benefits and risks are, and what the next step will be. If you feel overwhelmed, ask whether you can have the key points in writing or speak again with your breast care nurse.

Questions worth asking

• Has my case been reviewed by the multidisciplinary team?
• What did the team recommend, and why?
• What alternatives were discussed?
• How does this recommendation fit with my priorities and circumstances?
• What further tests, if any, are needed before a decision?
• Who will coordinate my care and who should I contact with questions?
• Can I have a copy of the clinic letter or a written summary?
• If I want more time or a second opinion, how can I arrange that?

If you feel unheard

If you are unsure whether your preferences have been understood, say so. You can ask for your concerns to be added to the information reviewed by the team. Your clinical nurse specialist is often the best first point of contact. In England, patient advice and liaison services can also offer advice if you are worried about communication or care. You are entitled to seek a second opinion, and your GP or hospital clinician can explain how to do this locally.

Shared decision making does not mean you must choose alone. It means your values, questions and circumstances are considered alongside clinical evidence. The MDT is one part of that process; you remain central to it.

Breast Cancer Haven offers information and emotional support for people affected by breast cancer. If you would like help preparing for appointments or making sense of your options, talking things through with a trained supporter can be a useful next step.